THRB and metabolic dysfunction-associated steatotic liver disease: Using this cutpoint on histologically low-risk samples with F0 and F1 fibrosis, THRB regulon activity identified a subset of MASLD patients with high risk of hepatic decompensation (Extended Data Fig. 8).